J&J inherited the Javelin catheter as part of its $13.1bn acquisition of Shockwave Medical, which completed in June 2024.

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Netherlands-based diagnostics imaging company Royal Philips announced the enrolment of its first patient in the US THRO IDE ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, ...

The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment ...

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

"Abbott touts long-term efficacy for dissolvable Esprit BTK stent" was originally created and published by Medical Device ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced ...

Semler Scientific mirrors MicroStrategy's Bitcoin strategy, raising $2.5M through share sales while growing holdings to 1,058 ...